NCT06261710 Intrapartum Ultrasound in Labor: Sonography Only, Few Internal Examinations
| NCT ID | NCT06261710 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Larry Hinkson |
| Condition | Labor Complication |
| Study Type | INTERVENTIONAL |
| Enrollment | 356 participants |
| Start Date | 2024-02-27 |
| Primary Completion | 2029-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 356 participants in total. It began in 2024-02-27 with a primary completion date of 2029-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, randomized trial to determine whether the use of sonographic parameters during labor results in less intrapartum infection compared to traditional invasive examination. Other secondary outcomes include maternal satisfaction and overall birth outcomes.
Eligibility Criteria
Inclusion Criteria: * Pregnant women of at least 18 years of age with a singleton in the cephalic position * Spontaneous onset of labor; births after induction of labor with otherwise suitable inclusion and exclusion criteria are also permitted. Exclusion Criteria: * Emergency situations such as maternal or fetal bleeding * Indication for urgent delivery by caesarean section * Pathological cardiotocogram * non-cephalic positions * under 18 years of age * women giving birth who are unable to give consent
Contact & Investigator
Larry Hinkson, FRCOG
PRINCIPAL INVESTIGATOR
Charité University Hospital Department of Obstetrics
Frequently Asked Questions
Who can join the NCT06261710 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 60 Years, studying Labor Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06261710 currently recruiting?
Yes, NCT06261710 is actively recruiting participants. Contact the research team at Larry.Hinkson@charite.de for enrollment information.
Where is the NCT06261710 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT06261710 clinical trial?
NCT06261710 is sponsored by Larry Hinkson. The principal investigator is Larry Hinkson, FRCOG at Charité University Hospital Department of Obstetrics. The trial plans to enroll 356 participants.